<DOC>
	<DOCNO>NCT00107731</DOCNO>
	<brief_summary>The purpose study determine whether quetiapine use adjunct lithium divalproex safe effective maintenance treatment adult patient Bipolar I Disorder . The study consist enrollment 2 phase , Open-label treatment Phase Randomized treatment Phase . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Efficacy &amp; Safety Seroquel Plus Mood Stabilizer Maintenance Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>A diagnosis Bipolar I Disorder , Most recent episode Manic ( 296.4x ) , Bipolar I Disorder , Most Recent Episode Depressed ( 296.5x ) , Bipolar I Disorder , Most recent Episode Mixed ( 296.6x ) , without psychotic feature , define Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) At least 1 manic , depressed , mixed episode 2 year prior index episode . Able understand comply requirement study . Diagnosis anxiety disorder define DSMIV , treat medication within past year . Known intolerance lack response quetiapine fumarate assign mood stabilizer , judge investigator . Previously randomize study D1447C00126</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Bipolar I Disorder</keyword>
	<keyword>Manic Depressive Disorder</keyword>
	<keyword>Manic Depression</keyword>
</DOC>